Adaptive Biotechnologies (ADPT) Other financing activities (2018 - 2026)

Adaptive Biotechnologies has disclosed Other financing activities across 9 years of filings, most recently posting $5.4 million for Q2 2026.

• In Q2 2026, Other financing activities rose 234.29% year-over-year to $5.4 million; the TTM figure through Jun 2026 stood at $21.2 million (up 193.65% YoY), while the FY2025 annual figure was $17.9 million, up 7318.67% from the prior year.
• Other financing activities came in at $5.4 million for Q2 2026 at Adaptive Biotechnologies, up from $5.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $116.8 million in Q4 2022 to a low of $17000.0 in Q3 2023.
• Average Other financing activities over 5 years is $8.6 million, with a median of $1.5 million recorded in 2023.
• Year-over-year, Other financing activities slumped 99.93% in 2023 and surged 12288.64% in 2025.
• Over 5 years, Other financing activities stood at $116.8 million in 2022, then tumbled by 99.93% to $87000.0 in 2023, then soared by 45.98% to $127000.0 in 2024, then soared by 7092.13% to $9.1 million in 2025, then slumped by 41.08% to $5.4 million in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $5.4 million in Q2 2026, $5.0 million in Q1 2026, and $9.1 million in Q4 2025.